跳至主要内容
临床试验/NCT03191656
NCT03191656进行中(未招募)不适用

A Post-Market Clinical Follow-up Study to Evaluate the Corvia Medical, Inc. InterAtrial Shunt Device - IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure

Corvia Medical54 个研究点 分布在 2 个国家目标入组 500 人开始时间: 2017年3月12日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
500
试验地点
54
主要终点
Serious Adverse Events

研究概览

简要总结

This is a post market trial to be conducted at sites in Germany. The device has CE approval in the EU. The purpose of this observational registry is to collect post market data in consecutive patients treated with the IASD System II, to further evaluate efficacy, safety and quality of life outcomes as a new treatment for patients with heart failure in a "real world" practice setting.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • This is a post market registry so no criteria requirements (only recommendations).

排除标准

  • 未提供

结局指标

主要结局

Serious Adverse Events

时间窗: 30 days

Device and or procedure related serious adverse cardiac events

Quality of Life Improvement (EQ5D)

时间窗: 12 months

Improvement in EQ5D score

Quality of Life Improvement (KCCQ score)

时间窗: 12 months

Improvement in KCCQ score

New York Heart Classification

时间窗: 12 months

Improvement in NYHA Classification

次要结局

未报告次要终点

研究者

发起方
Corvia Medical
申办方类型
Industry
责任方
Sponsor

研究点 (54)

Loading locations...

相似试验